20Jan 2017

CORONARY ARTERY DISEASE IN RHEUMATOID ARTHRITIS –PREVALENCE,PATHOPHYSIOLOGY,RISK AND TREATMENT

  • Pri-Med Care, Lewisville Texas, USA RGCP, Bhopal, India *Corresponding author: Maria Aziz, Pri-Med Care, Lewisville Texas, USA
Crossref Cited-by Linking logo
  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Coronary Artery Disease (CAD),is a significant contributor morbidity and mortality in Rheumatoid Arthritis ( RA) .1 Familiarity with the pathophysiology of coronary atherosclerosis will have important practical implications for patient care .Insights in to the mechanisms of thrombosis will give further insight into the concomitant therapy used during acute revascularization.2The purpose of this review is thorough understanding of the connection between atherosclerosis and RA and stress in accurate risk stratification in RA patients and timely intervention to improve outcomes .The review also highlights comprehensive collaboration between Rheumatologist and cardiologist to help in prevention of cardiovascular diseases in RA patients and improve patient care in a total spectrum.


  1. Solomon DH, Karlson EW, Rimm EB, et al: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-1307.
  2. Edwards CJ, Syddall H, Goswami R, et al: The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men. Heart 2007;93(10):1263-1267.
  3. Heliövaara M, Aho K, Knekt P, et al: Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis 1995;54(10):811-814.
  4. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR: Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997;24:445-451.
  5. Libby P: Inflammation in atherosclerosis. Nature 2002;420(6917):868-874.
  6. Jawien J: New insights into immunological aspects of atherosclerosis. Pol Arch Med Wewn 2008;118(3):127-131.
  7. Farragher TM, Goodson NJ, Naseem H, et al: Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 2008;58(2):359-369.
  8. Harvey EJ, Ramji DP: Interferon-gamma and atherosclerosis: Pro- or anti-atherogenic? Cardiovasc Res 2005;67(1):11-20
  9. Shah PK: Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med 1998;3(3):199-206.
  10. Aubry MC, Riehle DL, Edwards WD, et al: B-Lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: Preliminary observations. CardiovascPathol 2004;13(4):233-236.
  11. Pober JS: Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found Symp 1987;131:170-184.
  12. Pasceri V, Willerson JT, Yeh ET: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102(18):2165-2168.
  13. Aziz M, Yadav KS. Atherosclerosis: An extra articular Manifestation of Rheumatoid Arthritis AnnClin Lab Res. 2016, 4: 4.
  14. Aziz M, Yadav KS (2016) Role of Traditional Risk Factors, Inflammation and DMARDs in Cardiovascular Diseases in Rheumatoid  Arthritis and Management of Lipid profile J Autoimmune Disord 2: 3. doi: 10.21767/2471-8513.100026
  15. Aziz M, Yadav KS. Pathogenesis of Atherosclerosis. Med Clin Rev. 2016, 2:3.
  16. Chung CP, Oeser A, Solus JF, et al: Inflammation-associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum 2008;58(7):2105-2112.
  17. Yalamanchili K, Aronow WS, Kilaru R, et al: Coronary artery disease is more severe in older persons with rheumatoid arthritis than in older persons without rheumatoid arthritis. Cardiol Rev 2006;14(2):55-56.
  18. Turesson C, McClelland RL, Christianson TJ, Matteson EL: Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66(1):70-75.
  19. Aubry MC, Maradit-Kremers H, Reinalda MS, et al: Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007;34(5):937-942.
  20. Asanuma Y, Chung CP, Oeser A, et al: Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis 2007;195(2):e135-e141.
  21. Chung CP, Oeser A, Solus JF, et al: Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008;196(2):756-763.
  22. Omland T, Ueland T, Jansson AM, et al: Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am CollCardiol 2008;51(6):627-633.
  23. Kao AH, Krishnaswami S, Cunningham A, et al: Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis. J Rheumatol 2008;35(1):61-69.
  24. Dessein PH, Norton GR, Woodiwiss AJ, et al: Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 2007;34(5):943-951.
  25. Avalos I, Chung CP, Oeser A, et al: Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J Rheumatol 2007;34(12):2388-2394.
  26. Ciftci O, Yilmaz S, Topcu S, et al: Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis. Atherosclerosis 2008;198(2):332-337.

[Maria Aziz and K.S. Yadav. (2017); CORONARY ARTERY DISEASE IN RHEUMATOID ARTHRITIS –PREVALENCE,PATHOPHYSIOLOGY,RISK AND TREATMENT Int. J. of Adv. Res. 5 (Jan). 218-222] (ISSN 2320-5407). www.journalijar.com


Maria Aziz
Pri-Med Care, Lewisville Texas, USA

DOI:


Article DOI: 10.21474/IJAR01/2741      
DOI URL: http://dx.doi.org/10.21474/IJAR01/2741